EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation

Dhanu Gupta, Sara Orehek iD, Janne Turunen, Liz O'Donovan, Michael J Gait, Samir El-Andaloussi, Matthew J A Wood

Cells · 15.09.2023 · 12 (18) · 2285

DOI: 10.3390/cells12182285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 15.09.2023. Verfasst von Dhanu Gupta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University of Oxford, Oxford OX3 7TY, UK. Hauptthemen laut MEDLINE: Interleukin-6, Cytokines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union H2020 EXPERT grant, Swedish Foundation of Strategic Research (SSF-IRC, FormulaEx), ERC DELIVER project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-6 (IL-6) is a pleiotropic cytokine that plays a crucial role in maintaining normal homeostatic processes under the pathogenesis of various inflammatory and autoimmune diseases. This context-dependent effect from a cytokine is due to two distinctive forms of signaling: cis-signaling and trans-signaling. IL-6 cis-signaling involves binding IL-6 to the membrane-bound IL-6 receptor and Glycoprotein 130 (GP130) signal-transducing subunit. By contrast, in IL-6 trans-signaling, complexes of IL-6 and the soluble form of the IL-6 receptor (sIL-6R) signal via membrane-bound GP130. Various strategies have been employed in the past decade to target the pro-inflammatory effect of IL-6 in numerous inflammatory disorders. However, their development has been hindered since these approaches generally target global IL-6 signaling, also affecting the anti-inflammatory effects of IL-6 signaling too. Therefore, novel strategies explicitly targeting the pro-inflammatory IL-6 trans-signaling without affecting the IL-6 cis-signaling are required and carry immense therapeutic potential. Here, we have developed a novel approach to specifically decoy IL-6-mediated trans-signaling by modulating alternative splicing in GP130, an IL-6 signal transducer, by employing splice switching oligonucleotides (SSO), to induce the expression of truncated soluble isoforms of the protein GP130. This isoform is devoid of signaling domains but allows for specifically sequestering the IL-6/sIL-6R receptor complex with high affinity in serum and thereby suppressing inflammation. Using the state-of-the-art Pip6a cell-penetrating peptide conjugated to PMO-based SSO targeting GP130 for efficient in vivo delivery, reduced disease phenotypes in two different inflammatory mouse models of systemic and intestinal inflammation were observed. Overall, this novel gene therapy platform holds great potential as a refined therapeutic intervention for chronic inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6CytokinesAnimalsMiceCytokine Receptor gp130InflammationOligonucleotides

Stichwörter der Autor:innen

IL-6 trans-signalinginflammationnucleic acid therapiesoligonucleotides

Substanzen

Interleukin-6Cytokine Receptor gp130CytokinesOligonucleotides

Autor:innen und Institutionen

  • Department of Paediatrics, University of Oxford, Oxford OX3 7TY, UK.
  • Biomolecular Medicine, Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institutet, 14151 Huddinge, Sweden.
  • Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

ORCID-Profile: Sara Orehek

Förderung

  • European Union H2020 EXPERT grant
  • Swedish Foundation of Strategic Research (SSF-IRC, FormulaEx)
  • ERC DELIVER project

Zitieren

APA

Gupta, D., Orehek, S., Turunen, J., O'Donovan, L., Gait, M. J., El-Andaloussi, S., & Wood, M. J. A. (2023). Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation. Cells, 12(18), 2285. https://doi.org/10.3390/cells12182285

Vancouver

Gupta D, Orehek S, Turunen J, O'Donovan L, Gait MJ, El-Andaloussi S, et al. Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation. Cells. 2023;12(18):2285. doi:10.3390/cells12182285

BibTeX
@article{Gupta2023,
  author = {Gupta, Dhanu and Orehek, Sara and Turunen, Janne and O'Donovan, Liz and Gait, Michael J and El-Andaloussi, Samir and Wood, Matthew J A},
  title = {Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {18},
  pages = {2285},
  doi = {10.3390/cells12182285}
}
Kostenlos starten →